VetMedGuide

Vet Med Guide

Companion animal in a veterinary exam setting with medication reference materials.
Pharmaceuticals2026-05-28 · 9 min read

Flea and Tick Medicine Poisoning in Dogs: Signs, Causes, and What To Do

Recognize the signs of flea and tick medicine poisoning in dogs, understand which active ingredients cause toxicity, and know when to seek emergency veterinary care.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

Flea and tick preventives are among the most commonly used veterinary products in dogs. Most are safe when used according to the label, but toxicity can occur — from accidental overdose, using the wrong product for the dog's size or species, ingesting a topical product, or a dog's individual sensitivity to an active ingredient.

This article covers the three main classes of flea and tick ingredients that cause poisoning in dogs, what the signs look like, how a veterinarian diagnoses and treats toxicity, and what owners can do to reduce risk.

Which flea and tick ingredients cause poisoning

Not all flea and tick products carry the same toxicity risk. The three classes responsible for most poisoning events in dogs are pyrethrins and pyrethroids, organophosphates, and isoxazolines. Each has a different mechanism, a different severity profile, and different treatment priorities.

Pyrethrins and pyrethroids

Pyrethrins are natural insecticides derived from chrysanthemum flowers. Pyrethroids are synthetic derivatives that are more stable and potent. These are the active ingredients in many over-the-counter topical spot-on treatments, flea shampoos, sprays, and some yard and household insecticides. Common pyrethroids include permethrin, cypermethrin, deltamethrin, and bifenthrin.

Pyrethrins and pyrethroids slow the inactivation of voltage-gated sodium channels in nerve cells, causing prolonged nerve firing. Insects are highly sensitive; mammals are much less so. Dogs tolerate these chemicals better than cats, but toxicity still occurs — especially when a concentrated dog product is overdosed, when a dog licks a freshly applied topical, or when a household or yard insecticide is applied too liberally and the dog has skin or oral contact.

Organophosphates

Organophosphates (OPs) are an older class of insecticide that inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine at nerve synapses. The result is sustained nerve stimulation — tremors, salivation, constricted pupils, and potentially fatal respiratory paralysis.

Organophosphates were once common in veterinary flea products but have largely been replaced by safer alternatives. Most modern OP exposure in dogs comes from agricultural and garden insecticides rather than pet-specific products. Chlorpyrifos, diazinon, malathion, and phosmet are examples. OP toxicity can be rapidly fatal depending on the dose and the specific compound.

Isoxazolines

Isoxazolines are the active ingredient class in newer oral and topical flea and tick preventives, including afoxolaner (NexGard), fluralaner (Bravecto), sarolaner (Simparica), and lotilaner (Credelio). They work by blocking GABA-gated and glutamate-gated chloride channels in arthropod neurons, paralyzing and killing fleas and ticks. Binding is selective for arthropod receptors over mammalian receptors, which is why most dogs tolerate these products well.

In September 2018, the FDA issued a safety communication alerting pet owners and veterinarians that isoxazoline products have been associated with neurologic adverse reactions — including muscle tremors, ataxia, and seizures — in some dogs and cats. The alert was updated in 2019 and 2021 to include additional products. The FDA still considers these products safe and effective for most animals but recommends that veterinarians review each patient's medical history before prescribing. Dogs with a prior seizure history may be at higher risk.

What poisoning looks like

Signs vary by ingredient class, dose, and route of exposure.

  • Pyrethrins and pyrethroids: signs typically appear within 1 to 12 hours of topical exposure. Oral ingestion of a topical product may accelerate onset. Skin irritation and paresthesia often appear first, progressing to systemic signs if a large dose was absorbed.
  • Organophosphates: signs can appear within 30 minutes of ingestion or inhalation. Skin exposure may delay onset up to 12 to 24 hours. OP toxicity progresses through muscarinic (excessive secretions), nicotinic (muscle effects), and central (neurologic) stages.
  • Isoxazolines: adverse reactions are usually seen within hours of dosing. Vomiting and GI signs may appear first; neurologic signs, when they occur, typically manifest within the first 24 hours.

Pyrethrin and pyrethroid signs

  • Paresthesia: tingling, scratching, restlessness at the application site
  • Excessive drooling and gagging
  • Vomiting
  • Ear twitching and paw flicking (mild cases)
  • Muscle tremors progressing to seizures (severe cases)
  • Ataxia (loss of coordination)
  • Weakness and collapse

Dogs may also show skin redness and hair loss at the application site. Mild signs like drooling and paw flicking often resolve on their own within hours to a few days. Severe neurologic signs require hospitalization.

Organophosphate signs

  • SLUDGE syndrome: salivation, lacrimation, urination, defecation, gastrointestinal upset, emesis
  • Constricted (pinpoint) pupils
  • Muscle tremors and weakness
  • Difficulty breathing from excessive airway secretions
  • Bradycardia (slow heart rate)
  • Seizures and collapse

OP toxicity can progress to respiratory failure and death. Any suspected organophosphate exposure warrants immediate emergency care.

Isoxazoline adverse reactions

  • Vomiting and diarrhea
  • Lethargy and decreased appetite
  • Muscle tremors
  • Ataxia (incoordination)
  • Seizures (in dogs with or without prior seizure history)

Isoxazoline adverse events are generally less severe than pyrethroid or organophosphate toxicity. Most reactions are mild and self-limiting, but seizures and neurologic signs do occur and should be evaluated by a veterinarian.

How a veterinarian diagnoses flea product toxicity

Diagnosis is primarily based on history of exposure and the clinical presentation. There is no single definitive blood test for pyrethroid or isoxazoline toxicity. Key diagnostic steps include:

  • Exposure history: what product was used, the active ingredient, the concentration, when it was applied or ingested, and whether the dog was within the correct weight range.
  • Physical examination: assessing neurologic status, pupil size, heart rate, respiratory effort, and muscle tone.
  • Baseline bloodwork: checking blood glucose, kidney function, and electrolyte levels, which can be affected by tremoring, seizures, and dehydration.
  • Cholinesterase activity: for suspected organophosphate exposure, measuring whole-blood cholinesterase activity can help confirm the diagnosis.

Treatment

There is no specific antidote for pyrethrin, pyrethroid, or isoxazoline toxicity. Treatment is centered on decontamination, symptomatic support, and monitoring. Organophosphate poisoning is the exception — atropine and 2-PAM (pralidoxime) are specific antidotes.

Decontamination

For topical exposure, the first step is bathing the dog with a mild liquid dish soap (such as Dawn) to remove residual product from the skin and coat. This should be done as soon as possible after exposure. Rinsing the mouth with water is recommended if the dog licked or ingested a topical product.

For recent oral ingestion (within one to two hours), a veterinarian may induce vomiting or administer activated charcoal to limit absorption. Induction of vomiting should only be performed by a veterinary professional — it is contraindicated with some products and can be dangerous if the dog is already neurologically impaired.

Supportive and symptomatic care

Dogs with neurologic signs typically require hospitalization for 48 to 72 hours. Supportive care may include:

  • Intravenous fluids to maintain hydration and support kidney function
  • Methocarbamol as a muscle relaxant for tremors
  • Anticonvulsants (such as diazepam or propofol) for seizure control
  • Temperature monitoring — sustained muscle activity from tremoring can cause dangerous hyperthermia
  • Blood glucose monitoring — tremoring and seizure activity can deplete glucose stores

For organophosphate toxicity, atropine is administered to counteract the muscarinic effects (excessive secretions, bradycardia, constricted pupils). 2-PAM (pralidoxime chloride) may be given to reactivate inhibited cholinesterase. Repeated doses may be needed.

Prognosis

With prompt veterinary care, the prognosis for pyrethrin and pyrethroid toxicity is generally good. Mild signs often resolve within hours to a few days. Dogs with severe neurologic signs — prolonged seizures, hyperthermia, or kidney involvement — have a more guarded prognosis.

Organophosphate toxicity has a more variable outcome depending on the compound, the dose, and how quickly treatment begins. Early decontamination and aggressive supportive care improve survival.

Isoxazoline adverse events in most dogs are self-limiting. Dogs that experience seizures after isoxazoline administration should not receive the product again, and a veterinarian should evaluate whether an underlying seizure disorder exists.

Reducing the risk of flea product poisoning

  • Use products only as labeled. Apply topical products at the correct dose for the dog's weight. Do not split a large-dog dose between two small dogs.
  • Keep dog products off cats. Cats are far more sensitive to pyrethrins and pyrethroids than dogs. Applying a dog flea product to a cat is a common cause of feline emergency toxicity.
  • Separate pets after topical application. Until a topical product has fully dried, keep treated dogs away from cats and other pets that may lick the application site.
  • Do not double-dose. If you miss a monthly dose, do not apply two doses at once. Consult the product label or your veterinarian for guidance on resuming.
  • Store products out of reach. Dogs that chew on and ingest flea and tick product packaging can receive a massive overdose.
  • Tell your veterinarian about seizure history. If your dog has a history of seizures or neurologic disease, your veterinarian can help select a flea and tick preventive with the lowest neurologic risk for that patient.
  • Report adverse events. If your dog has a reaction to a flea or tick product, report it to the product manufacturer (many have 24/7 support lines), the FDA, or the EPA (for pesticide-registered products). Adverse event reports help regulators track safety signals.

What to ask your veterinarian

If your dog is showing signs after a flea or tick product was applied or given:

  • What active ingredient was in the product, and is it a pyrethroid, organophosphate, or isoxazoline?
  • Should I bathe my dog before coming in, or bring the product packaging?
  • Is this an emergency that requires immediate hospitalization, or can I monitor at home?
  • If my dog had a reaction, which flea and tick products are safer alternatives?

Sources

Topics
Drug Safety & ToxicologyParasiticidesEmergency & Critical Care
Related Articles